Celularity Inc (CELU)

Currency in USD
0.758
+0.006(+0.76%)
Closed·
0.7580.000(0.00%)
·
CELU is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.7300.760
52 wk Range
0.6674.350
Key Statistics
Prev. Close
0.752
Open
0.731
Day's Range
0.73-0.76
52 wk Range
0.667-4.35
Volume
25.4K
Average Volume (3m)
122.4K
1-Year Change
-56.9318%
Book Value / Share
-1.34
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CELU Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Celularity Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
WBB Securities
Buy6.00+691.56%-UpgradeSep 09, 2025
WBB Securities
Buy6.00+691.56%-New CoverageAug 18, 2025

Earnings

Latest Release
Apr 30, 2026
EPS / Forecast
-0.86 / -1.50
Revenue / Forecast
4.1M / --
EPS Revisions
Last 90 days

CELU Income Statement

Compare CELU to Peers and Sector

Metrics to compare
CELU
Peers
Sector
Relationship
P/E Ratio
−0.2x−8.8x−0.4x
PEG Ratio
0.01−0.100.00
Price/Book
−0.6x2.6x2.6x
Price / LTM Sales
0.8x201.5x3.0x
Upside (Analyst Target)
-80.1%58.1%
Fair Value Upside
Unlock−19.3%8.2%Unlock

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn’s disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn’s) and degenerative disease; and PDA-002 for treating multiple sclerosis, rheumatoid arthritis, stroke, and diabetic peripheral neuropathy. The company also produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.

Employees
115

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.34M11.54%2.51M
Other Institutional Investors
6.99M24.16%5.26M
Public Companies & Retail Investors
18.61M64.30%14.00M
Total
28.95M100.00%21.78M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Genting Berhad17.78%5,147,3753,872
BlackRock Health Sciences Term Trust8.40%2,430,8331,829

People Also Watch

25.19
FLNC
+1.57%
76.04
EPAM
-0.78%
3.1000
SIDU
-4.02%
92.360
AXTI
+9.21%
3.100
LAES
-0.64%

FAQ

What Is the Celularity (CELU) Stock Price Today?

The Celularity stock price today is 0.758 USD.

What Stock Exchange Does Celularity Trade On?

Celularity is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Celularity?

The stock symbol for Celularity is "CELU."

What Is the Celularity Market Cap?

As of today, Celularity market cap is 21.190M USD.

What Is Celularity's Earnings Per Share (TTM)?

The Celularity EPS (TTM) is -3.586.

From a Technical Analysis Perspective, Is CELU a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Celularity Stock Split?

Celularity has split 1 times.

How Many Employees Does Celularity Have?

Celularity has 115 employees.

What is the current trading status of Celularity (CELU)?

As of Jun 22, 2026, Celularity (CELU) is trading at a price of 0.758 USD, with a previous close of 0.752 USD. The stock has fluctuated within a day range of 0.730 USD to 0.760 USD, while its 52-week range spans from 0.667 USD to 4.350 USD.

What Is the CELU Premarket Price?

CELU's last pre-market stock price is 0.730 USD. The pre-market share volume is 110.000, and the stock has decreased by -0.022, or -2.930%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.